These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6389825)

  • 1. Microbial kinetics of beta-lactam antibiotics against Escherichia coli.
    Tsuji A; Hamano S; Asano T; Nakashima E; Yamana T; Mitsuhashi S
    J Pharm Sci; 1984 Oct; 73(10):1418-22. PubMed ID: 6389825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic analysis and characterization of the bacterial regrowth after treatment of Escherichia coli with beta-lactam antibiotics.
    Hamano S; Tsuji A; Asano T; Tamai I; Nakashima E; Yamana T; Mitsuhashi S
    J Pharm Sci; 1984 Oct; 73(10):1422-7. PubMed ID: 6209382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transfer of resistance to the newer beta-lactam antibiotics in Czechoslovakia].
    Antal M; Krŏméry V; Schön E
    Cas Lek Cesk; 1990 Mar; 129(12):366-8. PubMed ID: 2187617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic modeling of bacterial kinetics: beta-lactam antibiotics against Escherichia coli.
    Li RC; Nix DE; Schentag JJ
    J Pharm Sci; 1994 Jul; 83(7):970-5. PubMed ID: 7965677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of anti-microbial resistance of Escherichia coli that caused infection in urogenital system].
    Cui WL; Xu DX; Li WL; Wang LX
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):940-2, 945. PubMed ID: 15321769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous pharmacodynamic analysis of the lag and bactericidal phases exhibited by beta-lactams against Escherichia coli.
    Li RC
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2306-10. PubMed ID: 8891135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations affecting the resistance of Escherichia coli K-12 to beta-lactam antibiotics.
    Hrebenda J; Heleszko H
    J Antimicrob Chemother; 1985 Aug; 16(2):149-56. PubMed ID: 3905746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial kinetics of drug action against gram-positive and gram-negative organisms. III: Effect of lincomycin and clindamycin combinations on Staphylococcus aureus and Escherichia coli.
    Heman-Ackah SM
    J Pharm Sci; 1975 Oct; 64(10):1621-6. PubMed ID: 1102659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint tolerance to beta-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA.
    Falla TJ; Chopra I
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3282-4. PubMed ID: 9835528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artesunate enhances the antibacterial effect of {beta}-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC.
    Li B; Yao Q; Pan XC; Wang N; Zhang R; Li J; Ding G; Liu X; Wu C; Ran D; Zheng J; Zhou H
    J Antimicrob Chemother; 2011 Apr; 66(4):769-77. PubMed ID: 21393180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of beta-lactamase production of multiple resistance to beta-lactam antibiotics in clinical isolates of Escherichia coli.
    Tsuji H; Ohashi Y; Okumura K; Tsuji A; Muto Y; Goto S
    Chemotherapy; 1982; 28(1):26-39. PubMed ID: 7035089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FL 1060: a new beta-lactam antibiotic with novel properties.
    Greenwood D; O'Grady F
    J Clin Pathol; 1973 Jan; 26(1):1-6. PubMed ID: 4348402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial kinetics of drug action against gram-positive and gram-negative organisms. II: Effect of clindamycin on Staphylococcus aureus and Escherichia coli.
    Heman-Ackah SM
    J Pharm Sci; 1975 Oct; 64(10):1612-20. PubMed ID: 241826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases.
    Bedenic B; Vranes J; Suto S; Zagar Z
    Int J Antimicrob Agents; 2005 Jun; 25(6):479-87. PubMed ID: 15894465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to beta-lactam antibiotics by re-modelling the active site of an E. coli penicillin-binding protein.
    Hedge PJ; Spratt BG
    Nature; 1985 Dec 5-11; 318(6045):478-80. PubMed ID: 3906408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance requirements of Escherichia coli ATCC 25922 in the presence of sub-inhibitory concentrations of various antibiotics.
    Lobry JR; Carret G; Flandrois JP
    J Antimicrob Chemother; 1992 Feb; 29(2):121-7. PubMed ID: 1506326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of O8-antigen in altering beta-lactam antibiotic susceptibilities in Escherichia coli.
    Sarkar SK; Ghosh AS
    FEMS Microbiol Lett; 2008 May; 282(1):59-64. PubMed ID: 18328080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outer-membrane penetration barriers as components of intrinsic resistance to beta-lactam and other antibiotics in Escherichia coli K-12.
    Scudamore RA; Beveridge TJ; Goldner M
    Antimicrob Agents Chemother; 1979 Feb; 15(2):182-9. PubMed ID: 106773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A regional survey of the resistance to beta-lactam antibiotics in clinical isolates of (facultative) aerobic micro-organisms.
    Stobberingh EE; Philips JM; Houben AW; van Boven CP
    Drugs; 1988; 35 Suppl 2():41-4. PubMed ID: 3135169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of new and novel beta-lactam antibiotics.
    Aoki H; Kunugita K; Hosoda J; Imanaka H
    Jpn J Antibiot; 1977 Dec; 30 Suppl():207-17. PubMed ID: 349191
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.